Linical

Linical is a global Contract Research Organization (CRO) founded in 2005 and headquartered in Osaka, Japan. The company provides drug development services spanning early-stage work through large-scale multinational clinical trials, covering Phases I-IV. It operates in more than 30 countries across North America, Europe and Asia-Pacific, and is publicly traded on the Tokyo Stock Exchange.

Its technical services include clinical trial management, biometrics, pharmacovigilance, regulatory affairs, drug development strategy, and site selection and feasibility. Work is organised around several lines of service: management of clinical trials across all phases; site identification and feasibility assessment; regulatory support for development programmes; biometrics for trial data analysis; drug safety and pharmacovigilance; and strategic guidance on drug development programmes.

Linical serves clients in pharmaceuticals and biotechnology, with activity in therapeutic areas including oncology, neurology and psychiatry, immunology and vaccines, and endocrinology and metabolic diseases. The firm describes its approach as combining a business perspective with clinical and medical expertise, with an emphasis on flexibility, guidance and strategic solutions for clients.